Procter & Gamble Health Limited (PGHL) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.278x

Based on the latest financial reports, Procter & Gamble Health Limited (PGHL) has a cash flow conversion efficiency ratio of 0.278x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.72 Billion ≈ $18.63 Million USD) by net assets (Rs6.20 Billion ≈ $67.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See PGHL net asset quality index to measure how much of total assets are equity-financed.

Procter & Gamble Health Limited - Cash Flow Conversion Efficiency Trend (2003–2024)

This chart illustrates how Procter & Gamble Health Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Procter & Gamble Health Limited to evaluate the quality of earnings relative to operating cash generation.

Procter & Gamble Health Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Procter & Gamble Health Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sunflower Pharmaceuticals Group Co Ltd SHE:002737	-0.029x
Success Electronics Ltd SHE:002289	0.049x
Northwest Pipe Company NASDAQ:NWPX	0.072x
ISC Co. Ltd KQ:095340	0.030x
Hunan Friendship&Apollo Commercial Co Ltd SHE:002277	0.016x
Guangdong Golden Dragon Development Inc SHE:000712	0.203x
Shanghai Chlor-Alkali Chemical Co Ltd A SHG:600618	0.012x
Trinity Capital Inc NASDAQ:TRIN	0.027x

Annual Cash Flow Conversion Efficiency for Procter & Gamble Health Limited (2003–2024)

The table below shows the annual cash flow conversion efficiency of Procter & Gamble Health Limited from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see Procter & Gamble Health Limited market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Rs5.37 Billion ≈ $58.07 Million	Rs1.76 Billion ≈ $19.02 Million	0.327x	-22.79%
2023-12-31	Rs5.38 Billion ≈ $58.21 Million	Rs2.28 Billion ≈ $24.69 Million	0.424x	+34.94%
2022-12-31	Rs7.51 Billion ≈ $81.21 Million	Rs2.36 Billion ≈ $25.52 Million	0.314x	+14.30%
2021-12-31	Rs6.16 Billion ≈ $66.67 Million	Rs1.70 Billion ≈ $18.33 Million	0.275x	-21.74%
2020-12-31	Rs7.04 Billion ≈ $76.10 Million	Rs2.47 Billion ≈ $26.74 Million	0.351x	+7.61%
2019-12-31	Rs9.06 Billion ≈ $98.02 Million	Rs2.96 Billion ≈ $32.00 Million	0.327x	+485.69%
2018-12-31	Rs15.40 Billion ≈ $166.56 Million	Rs-1.30 Billion ≈ $-14.10 Million	-0.085x	-215.68%
2017-12-31	Rs7.33 Billion ≈ $79.30 Million	Rs536.60 Million ≈ $5.80 Million	0.073x	-55.87%
2016-12-31	Rs6.45 Billion ≈ $69.80 Million	Rs1.07 Billion ≈ $11.58 Million	0.166x	+17.26%
2015-12-31	Rs5.92 Billion ≈ $63.97 Million	Rs836.60 Million ≈ $9.05 Million	0.141x	+1483.68%
2014-12-31	Rs5.54 Billion ≈ $59.95 Million	Rs49.50 Million ≈ $535.32K	0.009x	+937.95%
2013-12-31	Rs5.23 Billion ≈ $56.56 Million	Rs4.50 Million ≈ $48.67K	0.001x	-99.23%
2012-12-31	Rs4.84 Billion ≈ $52.31 Million	Rs542.60 Million ≈ $5.87 Million	0.112x	+280.13%
2011-12-31	Rs4.10 Billion ≈ $44.35 Million	Rs-255.40 Million ≈ $-2.76 Million	-0.062x	-132.70%
2010-12-31	Rs3.46 Billion ≈ $37.46 Million	Rs659.70 Million ≈ $7.13 Million	0.190x	+113.20%
2009-12-31	Rs4.67 Billion ≈ $50.54 Million	Rs417.40 Million ≈ $4.51 Million	0.089x	+936.50%
2008-12-31	Rs4.51 Billion ≈ $48.82 Million	Rs38.90 Million ≈ $420.69K	0.009x	-90.44%
2007-12-31	Rs4.23 Billion ≈ $45.74 Million	Rs381.10 Million ≈ $4.12 Million	0.090x	-56.34%
2006-12-31	Rs3.93 Billion ≈ $42.50 Million	Rs811.20 Million ≈ $8.77 Million	0.206x	-20.21%
2005-12-31	Rs2.98 Billion ≈ $32.24 Million	Rs771.20 Million ≈ $8.34 Million	0.259x	-18.21%
2004-12-31	Rs2.48 Billion ≈ $26.84 Million	Rs784.90 Million ≈ $8.49 Million	0.316x	-14.07%
2003-12-31	Rs1.96 Billion ≈ $21.22 Million	Rs722.30 Million ≈ $7.81 Million	0.368x	--

About Procter & Gamble Health Limited

NSE:PGHL India Drug Manufacturers - Specialty & Generic

Market Cap

$1.17 Billion

Rs107.92 Billion INR

Market Cap Rank

#8154 Global

#410 in India

Share Price

Rs6501.50

Change (1 day)

-1.56%

52-Week Range

Rs4778.60 - Rs6918.50

All Time High

Rs6918.50